Rate this item
(0 votes)

DGANIT COHEN

By Super User 24 November, 2016 878

Director of Human Resources. Dganit joined Immunovative Therapies in 2016 and has over 10 years of experience in Human Resources in her previous role in Ophir Optronics Teva. She provided guidance and leadership to senior managers in international organizations through various stages of growth and stabilization. Additionally, she has considerable experience in management, training, career development and employee relations. Dganit holds a Masters Degree in Anthropology from the Hebrew University in Jerusalem. And a Bachelors Degree in Human Resource from Ben Gurion University

Last modified on Sunday, 07 May 2017 07:54
Share

SPECIALITY INFORMATION

patients


Treatment strategy designed to use the power of the human immune system to kill tumors and prevent their recurrence.
No requirement for a matched donor or chemotherapy/radiation conditioning prior to treatment.
Innovative technology – proven and non-toxic.
read more

Healthcare professionals


Therapeutic anti-tumor vaccine developed from core break-through technology called the "Mirror Effect™“ which opens a pathway to treating patients with metastatic cancer that have failed all available therapy options.
Elicits a GVT-like mechanism without the GVHD toxicity.
read more

Investors


Privately-held Israeli biopharmaceutical company spin out from Hadassah-Hebrew University Medical Center with headquarters in Jerusalem.

Over 200 individual private shareholders and grant support from the Israel Office of the Chief Scientist.
read more